Cargando…
Methotrexat-Versorgung vor dem Einsatz von Biologika bei rheumatoider Arthritis: Eine Analyse der Leitliniengerechtigkeit
BACKGROUND: With the introduction of biologics the treatment landscape for patients with rheumatoid arthritis (RA) has rapidly expanded; however, according to German and European treatment guidelines the use of biologic disease-modifying antirheumatic drugs (bDMARD) is only indicated after insuffici...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495498/ https://www.ncbi.nlm.nih.gov/pubmed/34545429 http://dx.doi.org/10.1007/s00393-021-01086-0 |